Advent International will buy a 70% stake in Reckitt’s essential home business, which also includes brands such as Air Wick.

The British drugmaker was trying to revive the drug, which was pulled from U.S. markets in 2022 after failing a late-stage study. The setback from the U.S. FDA advisory vote comes at a time when GSK ...